Authors:
PELC A
PORTIER H
GEHANNO P
FIESSINGER S
ICHOU F
Citation: A. Pelc et al., COST-SAVING OF 5-DAY THERAPY WITH CEFPODOXIME PROXETIL VERSUS STANDARD 10-DAY BETA-LACTAM THERAPY FOR RECURRENT PHARYNGOTONSILLITIS IN ADULTS - A PROSPECTIVE GENERAL-PRACTICE STUDY, PharmacoEconomics, 10(3), 1996, pp. 239-250
Authors:
AUTRET E
VASMANT D
BEGAUD B
DUPORTAL HD
BOUTROY MJ
CEZARD JP
DELBOS L
ESCHWEGE E
GOUJARD J
ICHOU F
JACQZAIGRAIN E
KOUZAN S
LASSALE C
LEROY B
OSTINELLI J
PLETAN Y
PONS G
SAUVANET JP
SINGLAS E
TABURET AM
THERENEFENOGLIO MC
TILLEMENT JP
VASSAL G
SAINTSALVY B
Citation: E. Autret et al., DETERMINATION OF DRUG-DOSAGE IN PEDIATRIC S, Therapie, 50(4), 1995, pp. 381-386
Authors:
PORTIER H
CHAVANET P
WALDNERCOMBERNOUX A
KISTERMAN JP
GREY PC
ICHOU F
SAFRAN C
Citation: H. Portier et al., 5 VERSUS 10 DAYS TREATMENT OF STREPTOCOCCAL PHARYNGOTONSILLITIS - A RANDOMIZED CONTROLLED TRIAL COMPARING CEFPODOXIME PROXETIL AND PHENOXYMETHYL PENICILLIN, Scandinavian journal of infectious diseases, 26(1), 1994, pp. 59-66